Difference between revisions of "Stub"
m (→CP & Erlotinib) |
|||
Line 147: | Line 147: | ||
====Radiotherapy==== | ====Radiotherapy==== | ||
*Concurrent [[External_beam_radiotherapy|radiation therapy]] | *Concurrent [[External_beam_radiotherapy|radiation therapy]] | ||
+ | |||
+ | ==CP & Bexarotene== | ||
+ | {| class="wikitable" style="float:right; margin-left: 5px;" | ||
+ | |- | ||
+ | |[[#top|back to top]] | ||
+ | |} | ||
+ | CP & Bexarotene: '''<u>C</u>'''arboplatin, '''<u>P</u>'''aclitaxel, Bexarotene | ||
+ | ===Regimen=== | ||
+ | ====Chemotherapy==== | ||
+ | *[[Carboplatin (Paraplatin)]] | ||
+ | *[[Paclitaxel (Taxol)]] | ||
+ | *[[Bexarotene (Targretin)]] | ||
+ | |||
+ | ==CP & Cediranib== | ||
+ | {| class="wikitable" style="float:right; margin-left: 5px;" | ||
+ | |- | ||
+ | |[[#top|back to top]] | ||
+ | |} | ||
+ | CP & Cediranib: '''<u>C</u>'''arboplatin, '''<u>P</u>'''aclitaxel, Cediranib | ||
+ | ===Regimen=== | ||
+ | ====Chemotherapy==== | ||
+ | *[[Carboplatin (Paraplatin)]] | ||
+ | *[[Paclitaxel (Taxol)]] | ||
+ | ====Targeted therapy==== | ||
+ | *[[Cediranib (Recentin)]] | ||
+ | |||
+ | ==CP & Cetuximab== | ||
+ | {| class="wikitable" style="float:right; margin-left: 5px;" | ||
+ | |- | ||
+ | |[[#top|back to top]] | ||
+ | |} | ||
+ | CP & Cetuximab: '''<u>C</u>'''arboplatin, '''<u>P</u>'''aclitaxel, Cetuximab | ||
+ | ===Regimen=== | ||
+ | ====Chemotherapy==== | ||
+ | *[[Carboplatin (Paraplatin)]] | ||
+ | *[[Paclitaxel (Taxol)]] | ||
+ | ====Targeted therapy==== | ||
+ | *[[Cetuximab (Erbitux)]] | ||
==CP & Erlotinib== | ==CP & Erlotinib== | ||
Line 160: | Line 198: | ||
====Targeted therapy==== | ====Targeted therapy==== | ||
*[[Erlotinib (Tarceva)]] | *[[Erlotinib (Tarceva)]] | ||
+ | |||
+ | ==CP & Sorafenib== | ||
+ | {| class="wikitable" style="float:right; margin-left: 5px;" | ||
+ | |- | ||
+ | |[[#top|back to top]] | ||
+ | |} | ||
+ | CP & Sorafenib: '''<u>C</u>'''arboplatin, '''<u>P</u>'''aclitaxel, Sorafenib | ||
+ | ===Regimen=== | ||
+ | ====Chemotherapy==== | ||
+ | *[[Carboplatin (Paraplatin)]] | ||
+ | *[[Paclitaxel (Taxol)]] | ||
+ | ====Targeted therapy==== | ||
+ | *[[Sorafenib (Nexavar)]] | ||
+ | |||
+ | ==CP & Veliparib== | ||
+ | {| class="wikitable" style="float:right; margin-left: 5px;" | ||
+ | |- | ||
+ | |[[#top|back to top]] | ||
+ | |} | ||
+ | CP & Velaparib: '''<u>C</u>'''arboplatin, '''<u>P</u>'''aclitaxel, Velaparib | ||
+ | ===Regimen=== | ||
+ | ====Chemotherapy==== | ||
+ | *[[Carboplatin (Paraplatin)]] | ||
+ | *[[Paclitaxel (Taxol)]] | ||
+ | ====Targeted therapy==== | ||
+ | *[[Veliparib (ABT-888)]] | ||
==Docetaxel & Pertuzumab== | ==Docetaxel & Pertuzumab== |
Revision as of 13:39, 7 September 2020
Regimens that have not proven to be superior to a standard-of-care comparison and are thus unlikely to be expanded upon unless new evidence comes forward. This page is primarily to drive the Ontology.
Abiraterone & Enzalutamide
back to top |
Regimen
Hormonotherapy
ACP
back to top |
ACP: Atezolizumab, Carboplatin, Paclitaxel
Regimen
Immunotherapy
Chemotherapy
Afatinib & Vinorelbine
back to top |
Regimen
Chemotherapy
Targeted therapy
Bortezomib & Bevacizumab
back to top |
Regimen
Targeted therapy
Bortezomib & Siltuximab
back to top |
Regimen
Targeted therapy
BTH (Taxotere)
back to top |
BTH: Bevacizumab, Taxotere (Docetaxel), Herceptin (Trastuzumab)
Regimen
Chemotherapy
Targeted therapy
CAD
back to top |
CAD: Cyclophosphamide, Adriamycin (Doxorubicin), DDP (Cisplatin)
Regimen
Chemotherapy
Carboplatin & Epirubicin
back to top |
Regimen
Chemotherapy
Carboplatin & Topotecan
back to top |
Regimen
Chemotherapy
CE & Ipilimumab
back to top |
CE & Ipilimumab: Carboplatin, Etoposide, Ipilimumab
Regimen
Chemotherapy
Immunotherapy
CE & Thalidomide
back to top |
CE & Thalidomide: Carboplatin, Etoposide, Thalidomide
Regimen
Chemotherapy
Targeted therapy
Cisplatin & Methotrexate
back to top |
Regimen
Chemotherapy
Cisplatin, Pemetrexed, RT
back to top |
Regimen
Chemotherapy
Radiotherapy
- Concurrent radiation therapy
CP & Bexarotene
back to top |
CP & Bexarotene: Carboplatin, Paclitaxel, Bexarotene
Regimen
Chemotherapy
CP & Cediranib
back to top |
CP & Cediranib: Carboplatin, Paclitaxel, Cediranib
Regimen
Chemotherapy
Targeted therapy
CP & Cetuximab
back to top |
CP & Cetuximab: Carboplatin, Paclitaxel, Cetuximab
Regimen
Chemotherapy
Targeted therapy
CP & Erlotinib
back to top |
CP & Erlotinib: Carboplatin, Paclitaxel, Erlotinib
Regimen
Chemotherapy
Targeted therapy
CP & Sorafenib
back to top |
CP & Sorafenib: Carboplatin, Paclitaxel, Sorafenib
Regimen
Chemotherapy
Targeted therapy
CP & Veliparib
back to top |
CP & Velaparib: Carboplatin, Paclitaxel, Velaparib
Regimen
Chemotherapy
Targeted therapy
Docetaxel & Pertuzumab
back to top |
Regimen
Chemotherapy
Targeted therapy
Encorafenib monotherapy
back to top |
Regimen
Targeted therapy
EP & Ipilimumab
back to top |
EP & Ipilimumab: Etoposide, Platinol (Cisplatin), Ipilimumab
Regimen
Chemotherapy
Immunotherapy
EP, Tamoxifen, RT
back to top |
EP, GM-CSF, RT: Etoposide, Platinol (Cisplatin), Tamoxifen, Radiation Therapy
Regimen
Chemotherapy
Hormonotherapy
Radiotherapy
- Concurrent thoracic radiation therapy
FAP
back to top |
FAP: Fluorouracil, Alfa interferon, Platinol (Cisplatin)
Regimen
Chemotherapy
Immunotherapy
FEC & HP
back to top |
FEC & HP: Fluorouracil, Epirubicin, Cyclophosphamide, Herceptin (Trastuzumab), Pertuzumab
Regimen
Chemotherapy
Targeted therapy
FULV & Trimetrexate
back to top |
FULV & Trimetrexate: 5-FU & LeucoVorin (Folinic acid), Trimetrexate
Regimen
Chemotherapy
Ixabepilone & Bevacizumab
back to top |
Regimen
Chemotherapy
Targeted therapy
MFL
back to top |
MFL: Methyl-lomustine (MeCCNU), 5-FU & LeucoVorin (Folinic acid)
Regimen
Chemotherapy
Mitoxantrone & Hydrocortisone
back to top |
Regimen
Chemotherapy
Hormonotherapy
MTP
back to top |
MTP: Myocet (Non-pegylated liposomal doxorubicin), Trastuzumab, Paclitaxel
Regimen
Chemotherapy
Targeted therapy
PD & Pembrolizumab
back to top |
PD & Pembrolizumab: Pomalidomide, Dexamethasone, Pembrolizumab
Regimen
Targeted therapy
Immunotherapy
Pixantrone & Rituximab
back to top |
Regimen
Chemotherapy
Targeted therapy
TCHL (Taxotere)
back to top |
TCHL: Taxotere (Docetaxel), Carboplatin, Herceptin (Trastuzumab), Lapatinib
Regimen
Chemotherapy
Targeted therapy
TCL (Taxotere)
back to top |
TCL: Taxotere (Docetaxel), Carboplatin, Lapatinib
Regimen
Chemotherapy
Targeted therapy
TEC
back to top |
TEC: Taxol (Paclitaxel), Epirubicin, Carboplatin
Regimen
Chemotherapy
TG+Bev
back to top |
TG+Bev: Taxotere (Docetaxel), Gemcitabine, Bevacizumab
Regimen
Chemotherapy
Targeted therapy
TH (Taxol) & Everolimus
back to top |
TH & Everolimus: Taxol (Paclitaxel), Herceptin (Trastuzumab), Everolimus
Regimen
Chemotherapy
Targeted therapy
TL (Taxotere)
back to top |
TL: Taxotere (Docetaxel) & Lapatinib
Regimen
Chemotherapy
Targeted therapy
TX+Bev
back to top |
TX+Bev: Taxotere (Docetaxel), Xeloda (Capecitabine), Bevacizumab
Regimen
Chemotherapy
Targeted therapy
Vinorelbine & Hydrocortisone
back to top |
Regimen
Chemotherapy
Hormonotherapy
VTDC
back to top |
VTDC: Velcade (Bortezomib), Thalidomide, Dexamethasone, Cyclophosphamide